Treatment of overactive bladder in the older patient: Pooled analysis of three phase III studies of darifenacin, an M-3 selective receptor antagonist

J. Foote, K. Glavind, G. Kralidis, J.J. Wyndaele

Research output: Contribution to journalJournal articleResearchpeer-review

64 Citations (Scopus)
Original languageEnglish
JournalEuropean Urology
Pages (from-to)471-477
Number of pages7
Publication statusPublished - 2005
Externally publishedYes

Cite this